VIP treatment in hospitals risks patient safety, warns AIIMS doctors

Preferential treatment accorded to high-profile patients in hospitals can jeopardise patient safety and undermine equitable access to healthcare services, cautioned senior doctors at AIIMS Delhi. Dr M D Ray, Professor of Surgical Oncology at the institute, and Dr Hema Siri Kottu, an MCh student, examined the phenomenon known as "VIP syndrome" in a research article published in Oncology Reviews.

The doctors highlighted that pressure from patients or hospital administrators to divert scarce medical resources for influential individuals can lead to avoidable clinical complications. In resource-constrained healthcare settings, such preferential allocation poses particular risks to both the beneficiary and other patients awaiting care. The study examined the ethical and clinical challenges arising from deviations from standard medical protocols based on a patient's social or political status.

"While special accommodations for high-profile individuals may be acceptable if they do not compromise access or the quality of care for others, healthcare providers must remain vigilant," the authors noted. The doctors have advocated for institutional discussions on formulating uniform policies that safeguard equity in patient care across all hospital departments.

The research underscores the need for transparent documentation and institutional protocols to ensure that clinical decision-making remains evidence-based and equitable, regardless of a patient's status or influence.